Chunghwa
1762.TWChunghwa Chemical Synthesis & Biotech Co., Ltd. Price (1762.TW)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
78,092,000
(0.5197)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Chunghwa Chemical Synthesis & Biotech Co., Ltd.Currency: TWD
| YEAR | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
1.13B
+0% |
1.20B
+6% |
1.20B
+0% |
1.33B
+11% |
1.04B
-22% |
946.70M
-9% |
1.16B
+23% |
1.20B
+3% |
1.17B
-3% |
1.02B
-13% |
1.16B
+13% |
1.54B
+33% |
1.93B
+25% |
2.12B
+9% |
2.09B
-1% |
||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 598.40M | 745.35M | 747.08M | 809.29M | 668.49M | 649.95M | 755.74M | 784.21M | 760.38M | 667.94M | 688.01M | 856.84M | 985.31M | 1.16B | 1.33B | ||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
528.45M
+0% |
451.89M
-14% |
453.50M
+0% |
520.30M
+15% |
374.99M
-28% |
296.76M
-21% |
406.47M
+37% |
414.46M
+2% |
407.87M
-2% |
351.51M
-14% |
468.63M
+33% |
686.75M
+47% |
949.39M
+38% |
961.76M
+1% |
757.31M
-21% |
||||
| Gross Profit Ratio | (0.47%) | (0.38%) | (0.38%) | (0.39%) | (0.36%) | (0.31%) | (0.35%) | (0.35%) | (0.35%) | (0.34%) | (0.41%) | (0.44%) | (0.49%) | (0.45%) | (0.36%) | ||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 105.67M | 100.80M | 130.49M | 136.32M | 126.48M | 130.02M | 131.87M | 146.40M | 149.32M | 161.54M | 195.46M | 215.73M | 252.67M | 244.79M | 242.70M | ||||
| General and Administrative | 39.61M | 56.62M | 67.91M | 71.50M | 61.88M | 63.26M | 77.63M | 83.79M | 95.79M | 80.33M | 76.45M | 92.41M | 95.23M | 109.31M | 104.63M | ||||
| Selling, General & Admin... | 124.82M | 145.44M | 154.46M | 158.07M | 149.78M | 143.38M | 175.09M | 169.93M | 180.41M | 159.08M | 152.06M | 202.10M | 239.89M | 271.78M | 233.80M | ||||
| Selling & Marketing Exp... | 85.22M | 88.81M | 86.55M | 86.57M | 87.91M | 80.12M | 97.46M | 86.14M | 84.62M | 78.76M | 75.61M | 109.70M | 144.67M | 162.47M | 129.18M | ||||
| Depreciation and Amortiz... | 87.47M | 61.80M | 65.16M | 69.71M | 83.27M | 96.49M | 102.83M | 114.71M | 134.13M | 134.76M | 129.64M | 131.15M | 131.99M | 169.05M | 193.01M | ||||
| Other Expenses | 9.22M | 11.86M | 17.92M | 11.49M | 27.27M | 28.58M | 244.96M | 1.52M | 39.75M | 218.74M | 5.03M | 347.81M | 12.18M | 73.88M | 280.81M | ||||
| Total Operating Expenses | 230.50M | 246.24M | 284.94M | 294.39M | 276.26M | 273.41M | 306.96M | 316.33M | 329.73M | 320.62M | 347.52M | 417.83M | 492.57M | 516.57M | 757.31M | ||||
| Cost and Exponses | 828.89M | 991.59M | 1.03B | 1.10B | 944.75M | 923.35M | 1.06B | 1.10B | 1.09B | 988.56M | 1.04B | 1.27B | 1.48B | 1.67B | 1.81B | ||||
| Operating Income | |||||||||||||||||||
| Operating Income |
297.96M
+0% |
205.65M
-31% |
168.55M
-18% |
225.91M
+34% |
98.73M
-56% |
23.35M
-76% |
99.52M
+326% |
98.13M
-1% |
78.14M
-20% |
30.89M
-60% |
154.36M
+400% |
655.05M
+324% |
519.28M
-21% |
574.67M
+11% |
280.81M
-51% |
||||
| Operating Income Ratio | (0.26%) | (0.17%) | (0.14%) | (0.17%) | (0.09%) | (0.02%) | (0.09%) | (0.08%) | (0.07%) | (0.03%) | (0.13%) | (0.42%) | (0.27%) | (0.27%) | (0.13%) | ||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 50.00k | 56.00k | 217.00k | 29.00k | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 808.00k | 424.00k | 181.00k | 4.51M | 7.27M | ||||
| Interest Expenses | 19.17M | 10.09M | 2.27M | 9.79M | 12.32M | 14.02M | 8.37M | 6.56M | 8.35M | 10.87M | 10.62M | 4.76M | 3.32M | 9.71M | 19.44M | ||||
| Total Other Income/Exp... | -49,964,000.00 | 70.76M | 25.57M | -1,404,000.00 | 14.95M | 14.56M | 236.59M | -5,041,000.00 | 31.40M | 209.35M | 22.64M | 381.38M | 59.14M | 119.77M | 52.68M | ||||
| EBITDA | |||||||||||||||||||
| EBITDA | 354.63M | 348.31M | 261.56M | 289.80M | 182.00M | 148.42M | 447.31M | 214.36M | 252.01M | 165.73M | 250.75M | 786.21M | 651.27M | 743.72M | 545.93M | ||||
| EBITDA ratio | (0.35%) | (0.22%) | (0.22%) | (0.22%) | (0.20%) | (0.16%) | (0.38%) | (0.18%) | (0.22%) | (0.38%) | (0.25%) | (0.51%) | (0.34%) | (0.35%) | (0.26%) | ||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 247.99M | 276.42M | 194.12M | 206.46M | 113.68M | 37.91M | 336.11M | 93.09M | 109.54M | 240.25M | 143.74M | 650.30M | 497.61M | 583.31M | 333.49M | ||||
| Income Before Tax Ratio | (0.22%) | (0.23%) | (0.16%) | (0.16%) | (0.11%) | (0.04%) | (0.29%) | (0.08%) | (0.09%) | (0.24%) | (0.12%) | (0.42%) | (0.26%) | (0.28%) | (0.16%) | ||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 1.61M | 27.37M | 28.60M | 30.89M | 16.76M | 23.00M | 27.80M | 32.91M | 23.65M | 5.96M | 26.62M | 118.23M | 96.56M | 117.17M | 68.58M | ||||
| Net Income | |||||||||||||||||||
| Net Income | 245.11M
+0% |
187.00M
-24% |
170.99M
-9% |
175.56M
+3% |
96.83M
-45% |
14.59M
-85% |
308.36M
+2,013% |
60.28M
-80% |
85.77M
+42% |
234.25M
+173% |
117.00M
-50% |
531.87M
+355% |
400.78M
-25% |
465.87M
+16% |
264.91M
-43% |
||||
| Net Income Ratio | (0.22%) | (0.16%) | (0.14%) | (0.13%) | (0.09%) | (0.02%) | (0.27%) | (0.05%) | (0.07%) | (0.23%) | (0.10%) | (0.34%) | (0.21%) | (0.22%) | (0.13%) | ||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 3.62 | 2.62 | 2.20 | 2.32 | 1.25 | 0.19 | 3.98 | 0.78 | 1.11 | 3.02 | 1.51 | 6.86 | 5.17 | 6.01 | 3.42 | ||||
| Diluted EPS | 3.56 | 2.61 | 2.20 | 2.31 | 1.24 | 0.19 | 3.96 | 0.77 | 1.10 | 2.99 | 1.50 | 6.79 | 5.12 | 5.93 | 3.39 | ||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 67.70M | 71.43M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | ||||
| Diluted Share Outstanding | 68.89M | 71.65M | 77.90M | 77.94M | 77.86M | 77.78M | 77.93M | 78.00M | 78.20M | 78.33M | 78.20M | 78.33M | 78.32M | 78.50M | 78.09M | ||||